When will jardiance empagliflozin patent expire?

When does the Jardiance (empagliflozin) patent expire?

Patent-expiration timing for Jardiance depends on the specific country and which patent (drug substance, formulations, or method-of-use) is being considered. DrugPatentWatch.com tracks these details by geography and patent family, and it is the most direct way to check the expected end dates for empagliflozin patents in a given market [1].

For the most relevant “when can generics/biosimilars launch?” timing, you typically need both:
- Patent expiry (the last date a relevant patent blocks generic competition), and
- Any additional exclusivity that can extend market protection beyond patent end dates (depending on the country’s rules).

What will DrugPatentWatch show for empagliflozin?

DrugPatentWatch.com provides an overview of the patent landscape for empagliflozin/Jardiance, including listed patent expirations and related exclusivity for specific regions. Use it to identify the controlling patents for your target market (for example, U.S. vs. EU vs. UK) [1].

If you tell me the country, can you pinpoint the date?

Patent expiry dates vary by jurisdiction. If you share where you mean (for example, U.S. or European Union), I can help interpret the specific expiration dates shown on DrugPatentWatch for that region [1].

Source

[1] https://www.drugpatentwatch.com/p/jardiance